Phenothiazine-induced decompensation.
D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D001712:Biperiden / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014268:Trifluoperazine / Q000008:administration & dosage / Q000009:adverse effects*
D010919:Placebos; D001712:Biperiden; D014268:Trifluoperazine; D005476:Fluphenazine